HPA000285

antibody from Atlas Antibodies

Targeting: PIM2

Immunocytochemistry (Data presented on provider website)

Antibody Data

Product number

HPA000285

Provider

Atlas Antibodies

Proper citation

Atlas Antibodies Cat#HPA000285, RRID:AB_1079619

Product name

Anti-PIM2

Antibody type

Polyclonal

Reactivity

Human

Host

Rabbit

Conjugate

Unconjugated

Antigen sequence

SGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPA
TVWSLGILLYDMVCGDIPFERDQEILEAELHFPAH
VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP
AEDVPLNPSKGGPAPLAWSL


Isotype

IgG

Vial size

100 µl

Storage

Store at +4°C for short term storage. Long time storage is recommended at -20°C.

References

Submitted references

Identification of targetable kinases in idiopathic pulmonary fibrosis

Higo H, Ohashi K, Tomida S, Okawa S, Yamamoto H, Sugimoto S, Senoo S, Makimoto G, Ninomiya K, Nakasuka T, Nishii K, Taniguchi A, Kubo T, Ichihara E, Hotta K, Miyahara N, Maeda Y, Toyooka S, Kiura K
Respiratory Research 2022;23(1)

---

Positive regulation of PFKFB3 by PIM2 promotes glycolysis and paclitaxel resistance in breast cancer

Lu C, Qiao P, Sun Y, Ren C, Yu Z
Clinical and Translational Medicine 2021;11(4)

---

PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma

Brault L, Menter T, Obermann E, Knapp S, Thommen S, Schwaller J, Tzankov A
British Journal of Cancer 2012;107(3):491-500

---

Pim-selective inhibitor DHPCC-9 reveals Pim kinases as potent stimulators of cancer cell migration and invasion.

Santio NM, Vahakoski RL, Rainio EM, Sandholm JA, Virtanen SS, Prudhomme M, Anizon F, Moreau P, Koskinen PJ
Molecular cancer 2010 Oct 19;9:279